13C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application

Assessment of the liver function, and the need of constant monitoring of the organ's capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. Most commonly, the diagnostics is based on measurements of static biochemical parameters, which allow us to draw conclusions only indirectly about the function and the degree of damage of the organ. On the other hand, liver biopsy is an invasive procedure and therefore it is associated with a considerable risk of complications. Dynamic tests enable us to assess quantitatively the organ's functional reserve by analyzing the kinetics of the metabolization of the substrate by the liver. In practice applied are breath tests using substances such as aminopyrine, caffeine, methacetin, erythromycin (for assessment of the microsomal function); phenylalanine, galactose (for assessment of the cytosolic function); methionine, octanoate, ketoisocaproic acid (for assessment of the mitochondrial function). The test with 13C methacetin belongs to the best described and most widely applied methods in noninvasive liver function assessment. Due to the rising availability of this method, knowledge concerning its limitations and controversies regarding the methodology, as well as its usefulness in chosen groups of patients, seems to be vital.

[1]  Y. Ilan,et al.  Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic? , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[2]  S. Weber-Carstens,et al.  (13) C Breath Tests Are Feasible in Patients With Extracorporeal Membrane Oxygenation Devices. , 2016, Artificial organs.

[3]  L. Chan,et al.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products , 2016, Clinical Pharmacokinetics.

[4]  E. Poniewierka,et al.  13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease. , 2016, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[5]  C. Fierbinţeanu-Braticevici,et al.  Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C , 2014, The Indian journal of medical research.

[6]  A. Goede,et al.  Assessment of Hepatic Detoxification Activity: Proposal of an Improved Variant of the 13C-Methacetin Breath Test , 2013, PloS one.

[7]  K. Jonderko,et al.  Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism , 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[8]  K. Jonderko,et al.  13C-methacetin breath test correlates with clinical indices of liver disease severity in patients with primary biliary cirrhosis. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[9]  O. Pappo,et al.  Continuous 13C-Methacetin Breath Test Differentiates Biliary Atresia From Other Causes of Neonatal Cholestasis , 2013, Journal of pediatric gastroenterology and nutrition.

[10]  S. Wootton,et al.  Clinical Utility of 13C-Liver-Function Breath Tests for Assessment of Hepatic Function , 2012, Digestive Diseases and Sciences.

[11]  A. Gasbarrini,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? , 2012, Internal and Emergency Medicine.

[12]  K. Jonderko,et al.  C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations. , 2011, World journal of gastroenterology.

[13]  K. Jonderko,et al.  Interference of acute cigarette smoking with [13C]methacetin breath test , 2011, Isotopes in environmental and health studies.

[14]  Y. Ilan,et al.  Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology , 2009, Journal of breath research.

[15]  P. Neuhaus,et al.  Prediction of Postoperative Outcome After Hepatectomy With a New Bedside Test for Maximal Liver Function Capacity , 2009, Annals of surgery.

[16]  O. Pappo,et al.  A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT , 2008, Journal of viral hepatitis.

[17]  K. Jonderko,et al.  Exact profiles of 13CO2 recovery in breath air after per oral administration of [13C]methacetin in two groups of different ages , 2008, Isotopes in environmental and health studies.

[18]  R. Chapman,et al.  13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  F. Málek,et al.  Correlation of the functional liver mass with left ventricular ejection fraction and left atrial diameter in patients with congestive heart failure. , 2008, International journal of cardiology.

[20]  K. Wutzke,et al.  Effect of alcohol consumption on the liver detoxication capacity as measured by [13C]methacetin- and [methyl-13C]methionine-breath tests , 2008, Isotopes in environmental and health studies.

[21]  B. Braden,et al.  13C-breath tests: current state of the art and future directions. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  M. Fried,et al.  13C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry , 2007, Alimentary pharmacology & therapeutics.

[23]  A. Gasbarrini,et al.  13C-breath tests in the study of microsomal liver function. , 2004, European review for medical and pharmacological sciences.

[24]  A. Gasbarrini,et al.  13 C‐methacetin breath test and oxygen supply , 2003, Alimentary pharmacology & therapeutics.

[25]  G. Tisone,et al.  13C‐methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation , 2003, Alimentary pharmacology & therapeutics.

[26]  W. Fleig,et al.  13C‐Methacetin metabolism in patients with cirrhosis: relation to disease severity, haemoglobin content and oxygen supply , 2003, Alimentary pharmacology & therapeutics.

[27]  A. Gasbarrini,et al.  Study of liver function in healthy elderly subjects using the 13C‐methacetin breath test , 2003, Alimentary pharmacology & therapeutics.